FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roy Smythe

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Physiology

Capillary Permeability

Anatomy

Co-author Network

Publications

TOP 3
Richard C Frazee; John C Hendricks; Travis Isbell; Daniel C Jupiter; Justin L Regner; Randall W Smith; Stephen W Abernathy; Matthew Davis; W Roy Smythe
Are commercial negative pressure systems worth the cost in open abdomen management?
Devendra A Sawant; W Roy Smythe; Hayden W Stagg; Binu Tharakan; Richard P Tobin; Felicia A Hunter; M Karen Newell; Ed W Childs
Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock.
Jeremy L Yap; Xiaobo Cao; Kwan-Young Jung; Alexander D. Mackerell; Anjan Nan; Chander Peddaboina; W Roy Smythe; Kenno Vanommeslaeghe; Paul T Wilder; Stephen Fletcher
Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roy Smythe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard C Frazee; John C Hendricks; Travis Isbell; Daniel C Jupiter; Justin L Regner; Randall W Smith; Stephen W Abernathy; Matthew Davis; W Roy Smythe
Are commercial negative pressure systems worth the cost in open abdomen management?
Journal of the American College of Surgeons 2013;216(4):730-3; discussion 733-5.
2013: Devendra A Sawant; W Roy Smythe; Hayden W Stagg; Binu Tharakan; Richard P Tobin; Felicia A Hunter; M Karen Newell; Ed W Childs
Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock.
Shock (Augusta, Ga.) 2013;39(2):161-7.
2012: Jeremy L Yap; Xiaobo Cao; Kwan-Young Jung; Alexander D. Mackerell; Anjan Nan; Chander Peddaboina; W Roy Smythe; Kenno Vanommeslaeghe; Paul T Wilder; Stephen Fletcher
Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.
Organic & biomolecular chemistry 2012;10(15):2928-33.
2012: Binu Tharakan; John H Tinsley; Joseph Hellman; Felicia A Hunter; Alan R Parrish; Devendra A Sawant; W Roy Smythe; Ed W Childs
β-Catenin dynamics in the regulation of microvascular endothelial cell hyperpermeability.
Shock (Augusta, Ga.) 2012;37(3):306-11.
2012: Chander Peddaboina; Arun Rai; Philip Rascoe; M Karen Newell Rogers; W Roy Smythe; Richard P Tobin; Jeremy L Yap; Stephen Fletcher; Weihua Jiang; Daniel Jupiter; Xiaobo Cao
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
BMC cancer 2012;12():541.
2012: Philip A Rascoe; Xiaobo Cao; Daniel Jupiter; James E Littlejohn; W Roy Smythe
Molecular pathogenesis of malignant mesothelioma.
Expert reviews in molecular medicine 2012;14():e12.
2011: Robert E Merritt; Scott I Reznik; Marcelo C DaSilva; Dean M Donahue; Chuong D Hoang; W Roy Smythe; David J Sugarbaker; Richard I Whyte; Joseph B Shrager
Benign emptying of the postpneumonectomy space.
The Annals of thoracic surgery 2011;92(3):1076-81; discussion 1081-2.
2011: Devendra A Sawant; Binu Tharakan; Felicia A Hunter; W Roy Smythe; Ed W Childs
Role of β-catenin in regulating microvascular endothelial cell hyperpermeability.
The Journal of trauma 2011;70(2):481-7; discussion 487-8.
2011: Philip A Rascoe; Scott I Reznik; W Roy Smythe
Chondrosarcoma of the thorax.
Sarcoma 2011;2011():342879.
2011: Devendra A Sawant; Binu Tharakan; Ashton Adekanbi; Felicia A Hunter; W Roy Smythe; Ed W Childs
Inhibition of VE-cadherin proteasomal degradation attenuates microvascular hyperpermeability.
Microcirculation (New York, N.Y. : 1994) 2011;18(1):46-55.
2010: Binu Tharakan; Felicia A Hunter; W Roy Smythe; Ed W Childs
Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock.
Clinical and experimental pharmacology & physiology 2010;37(9):939-44.
2010: Ed W Childs; Binu Tharakan; Felicia A Hunter; W Roy Smythe
17beta-estradiol mediated protection against vascular leak after hemorrhagic shock: role of estrogen receptors and apoptotic signaling.
Shock (Augusta, Ga.) 2010;34(3):229-35.
2010: W Roy Smythe
The future of academic surgery.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(5):768-74.
2010: W Roy Smythe
On being a doctor. Mattie's visit.
Annals of internal medicine 2010;152(7):470-1.
2010: Ed W Childs; Binu Tharakan; Suliat Nurudeen; Thomas L Delmas; Joseph Hellman; Tasheika Christie; Felicia A Hunter; W Roy Smythe
Cyclosporine A--protection against microvascular hyperpermeability is calcineurin independent.
American journal of surgery 2010;199(4):542-8.
2010: Lidong Zhang; James E Littlejohn; Yu Cui; Xiaobo Cao; Chander Peddaboina; W Roy Smythe
Characterization of bortezomib-adapted I-45 mesothelioma cells.
Molecular cancer 2010;9():110.
2010: Binu Tharakan; J Greg Whaley; Felicia A Hunter; W Roy Smythe; Ed W Childs
(-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock.
Shock (Augusta, Ga.) 2010;33(1):56-63.
2009: Xiaobo Cao; James Littlejohn; Charles Rodarte; Lidong Zhang; Benjamin Martino; Philip Rascoe; Kamran Hamid; Daniel Jupiter; W Roy Smythe
Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.
The American journal of pathology 2009;175(5):2207-16.
2009: Binu Tharakan; Juliet G Holder-Haynes; Felicia A Hunter; W Roy Smythe; Ed W Childs
Cyclosporine A prevents vascular hyperpermeability after hemorrhagic shock by inhibiting apoptotic signaling.
The Journal of trauma 2009;66(4):1033-9.
2009: Shanda H Blackmon; David C Rice; Arlene M Correa; Reza Mehran; Joe B Putnam; W Roy Smythe; Jon-Cecil M Walkes; Garrett L Walsh; Cesar Moran; harpreet singh; Ara A Vaporciyan; Michael Reardon
Management of primary pulmonary artery sarcomas.
The Annals of thoracic surgery 2009;87(3):977-84.
2009: Peter H Norman; Peter F Thall; Ronaldo V Purugganan; Bernhard J C J Riedel; Dilip R Thakar; David C Rice; Lisa Huynh; Wei Qiao; Sijin Wen; W Roy Smythe
A possible association between aprotinin and improved survival after radical surgery for mesothelioma.
Cancer 2009;115(4):833-41.
2009: Binu Tharakan; Robert Corprew; Felicia A Hunter; J Greg Whaley; W Roy Smythe; Ed W Childs
17beta-estradiol mediates protection against microvascular endothelial cell hyperpermeability.
American journal of surgery 2009;197(2):147-54.
2008: Binu Tharakan; Felicia A Hunter; W Roy Smythe; Ed W Childs
Alpha-lipoic acid attenuates hemorrhagic shock-induced apoptotic signaling and vascular hyperpermeability.
Shock (Augusta, Ga.) 2008;30(5):571-7.
2008: James E Littlejohn; Xiaobo Cao; Steven D Miller; Mustafa K Ozvaran; Daniel Jupiter; Lidong Zhang; Charles Rodarte; W Roy Smythe
Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
International journal of cancer. Journal international du cancer 2008;123(1):202-8.
2008: Ed W Childs; Binu Tharakan; Nickolas Byrge; John H Tinsley; Felicia A Hunter; W Roy Smythe
Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock.
American journal of physiology. Heart and circulatory physiology 2008;294(5):H2285-95.
2008: W Roy Smythe; Scott I Reznik
Optimal exposure of thoracic inlet vascular structures: transmanubrial approach.
Seminars in vascular surgery 2008;21(1):21-4.
2008: W Roy Smythe
Bring out your dead?
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 2008;71(4):10-4; discussion 15.
2007: David C Rice; Craig W Stevens; Arlene M Correa; Ara A Vaporciyan; Anne S Tsao; Kenneth Forster; Garrett L Walsh; Stephen G Swisher; Wayne L Hofstetter; Reza J Mehran; Jack A Roth; Zhongxing Liao; W Roy Smythe
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
The Annals of thoracic surgery 2007;84(5):1685-92; discussion 1692-3.
2007: David C Rice; W Roy Smythe; Zhongxing Liao; Thomas Guerrero; Joe Y Chang; Mary F McAleer; Melenda Jeter; Arlene Correa; Ara A Vaporciyan; H Helen Liu; Ritsuko Komaki; Kenneth Forster; Craig W Stevens
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
International journal of radiation oncology, biology, physics 2007;69(2):350-7.
2007: Faisal G Bakaeen; David Rice; Arlene M Correa; Garrett L Walsh; Ara A Vaporciyan; Joe B Putnam; Stephen G Swisher; Jack A Roth; Joseph Huh; Danny Chu; W Roy Smythe
Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.
The Annals of thoracic surgery 2007;84(3):982-6.
2007: Luis H Camacho; Ana Mora-Bowen; Reginald F Munden; W Roy Smythe; Nelson G Ordoñez
Malignant mesothelioma: natural history, pathologic features and future therapies.
The American journal of medicine 2007;120(7):e7-9.
2007: Xiaobo Cao; Charles Rodarte; Lidong Zhang; Clinton D Morgan; James Littlejohn; W Roy Smythe
Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma.
Cancer biology & therapy 2007;6(2):246-52.
2006: Michael J Reardon; S Chris Malaisrie; Jon-Cecil M Walkes; Ara A Vaporciyan; David C Rice; W Roy Smythe; Clement A DeFelice; Zbigniew J Wojciechowski
Cardiac autotransplantation for primary cardiac tumors.
The Annals of thoracic surgery 2006;82(2):645-50.
2005: Craig W Stevens; Kenneth M Forster; W Roy Smythe; David Rice
Radiotherapy for mesothelioma.
Hematology/oncology clinics of North America 2005;19(6):1099-115, vii.
2005: Linda Martin; Arlene M Correa; Wayne L Hofstetter; Waun Ki Hong; Ritsuko Komaki; Joe B Putnam; David C Rice; W Roy Smythe; Stephen G Swisher; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
The Journal of thoracic and cardiovascular surgery 2005;130(6):1601-10.
2005: David C Rice; Jeremy J Erasmus; Craig W Stevens; Ara A Vaporciyan; Judy S Wu; Anne S Tsao; Garrett L Walsh; Stephen G Swisher; Wayne L Hofstetter; Nelson G Ordonez; W Roy Smythe
Extended surgical staging for potentially resectable malignant pleural mesothelioma.
The Annals of thoracic surgery 2005;80(6):1988-92; discussion 1992-3.
2005: Anthony J Ascioti; Wayne L Hofstetter; Michael J Miller; David C Rice; Stephen G Swisher; Ara A Vaporciyan; Jack A Roth; Joe B Putnam; W Roy Smythe; Barry W Feig; Paul F Mansfield; Peter W T Pisters; Marla T Torres; Garrett L Walsh
Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.
The Journal of thoracic and cardiovascular surgery 2005;130(5):1391-8.
2005: Philip A Rascoe; Xiaobo Cao; Jonathan C Daniel; Steven D Miller; W Roy Smythe
Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma.
The Journal of thoracic and cardiovascular surgery 2005;130(2):393-400.
2005: Jeremy J Erasmus; Mylene T Truong; W Roy Smythe; Reginald F Munden; Edith M Marom; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Bradley S Sabloff; Lyle D Broemeling; Craig W Stevens; Katherine M W Pisters; Donald A Podoloff; Homer A Macapinlac
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
The Journal of thoracic and cardiovascular surgery 2005;129(6):1364-70.
2005: Charles Lu; Roman Perez-Soler; Bilal Piperdi; Garrett L Walsh; Stephen G Swisher; W Roy Smythe; Hyung J Shin; Jae Y Ro; Lei Feng; Mylene T Truong; Adiseshu Yalamanchili; Gabriel Lopez-Berestein; Waun Ki Hong; Abdul R Khokhar; Dong M Shin
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3495-501.
2005: Hongbo Zhu; Wei Guo; Lidong Zhang; John J Davis; Shuhong Wu; Fuminori Teraishi; Xiaobo Cao; W Roy Smythe; Bingliang Fang
Enhancing TRAIL-induced apoptosis by Bcl-X(L) siRNA.
Cancer biology & therapy 2005;4(4):393-7.
2005: Reginald F Munden; Jeremy J Erasmus; W Roy Smythe; John E Madewell; Kenneth Forster; Craig W Stevens
Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance.
AJR. American journal of roentgenology 2005;184(4):1091-5.
2005: Hongbo Zhu; Wei Guo; Lidong Zhang; John J Davis; Fuminori Teraishi; Shuhong Wu; Xiaobo Cao; Jonathan Daniel; W Roy Smythe; Bingliang Fang
Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
Molecular cancer therapeutics 2005;4(3):451-6.
2005: David C Rice; Arlene M Correa; Ara A Vaporciyan; Nidhi Sodhi; W Roy Smythe; Stephen G Swisher; Garrett L Walsh; Joe B Putnam; Ritsuko Komaki; Jaffer A Ajani; Jack A Roth
Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
The Annals of thoracic surgery 2005;79(2):391-7; discussionn 391-7.
2004: Stephen G Swisher; Jeremy J Erasmus; Mary Maish; Arlene M Correa; Homer A Macapinlac; Jaffer A Ajani; James D Cox; Ritsuko Komaki; David Hong; Hoon K Lee; Joe B Putnam; David C Rice; W Roy Smythe; Linh Thai; Ara A Vaporciyan; Garrett L Walsh; Tsung-Teh Wu; Jack A Roth
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Cancer 2004;101(8):1776-85.
2004: Stephen G Swisher; Mary Maish; Jeremy J Erasmus; Arlene M Correa; Jaffer A Ajani; Robert S Bresalier; Ritsuko Komaki; Homer A Macapinlac; Reginald F Munden; Joe B Putnam; David Rice; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Tsung-Teh Wu; Jack A Roth
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
The Annals of thoracic surgery 2004;78(4):1152-60; discussion 1152-60.
2004: Banke Agarwal; Stephen G Swisher; Jaffer A Ajani; Kaitlyn Kelly; Christina Fanning; Ritsuko Komaki; Joe B Putnam; Emad M Abu-Hamda; Kimber L Molke; Garrett L Walsh; Arlene M Correa; Linus Ho; Zhongxing Liao; Patrick M Lynch; David C Rice; W Roy Smythe; Craig W Stevens; Ara A Vaporciyan; James Yao; Jack A Roth
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection.
The American journal of gastroenterology 2004;99(7):1258-66.
2004: Mustafa K Ozvaran; Xiaobo X Cao; Steven D Miller; Brett A Monia; Waun Ki Hong; W Roy Smythe
Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
Molecular cancer therapeutics 2004;3(5):545-50.
2004: Mark S Allen; Douglas E Wood; Ronald W Hawkinson; David H Harpole; Robert J McKenna; Garrett L Walsh; Eric Vallieres; Daniel L Miller; Francis C Nichols; W Roy Smythe; Robert D Davis
Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection.
The Annals of thoracic surgery 2004;77(5):1792-801.
2004: Ara A Vaporciyan; Arlene M Correa; David C Rice; Jack A Roth; W Roy Smythe; Stephen G Swisher; Garrett L Walsh; Joe B Putnam
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.
The Journal of thoracic and cardiovascular surgery 2004;127(3):779-86.
2004: Ara A Vaporciyan; Joe B Putnam; W Roy Smythe
The potential role of aprotinin in the perioperative management of malignant tumors.
Journal of the American College of Surgeons 2004;198(2):266-78.
2004: W Roy Smythe
Protected time.
Surgery 2004;135(2):232-4.
2004: Jonathan C Daniel; W Roy Smythe
The role of Bcl-2 family members in non-small cell lung cancer.
Seminars in thoracic and cardiovascular surgery 2004;16(1):19-27.
2004: Duncan J Stewart; John G Edwards; W Roy Smythe; David A Waller; Kenneth J O'Byrne
Malignant pleural mesothelioma--an update.
International journal of occupational and environmental health 2004;10(1):26-39.
2003: Judith W Cook; Daniel H Sterman; shashank singhal; W Roy Smythe; Larry R Kaiser
Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models.
Lung cancer (Amsterdam, Netherlands) 2003;42(3):263-74.
2003: Hoon K Lee; Ara A Vaporciyan; James D Cox; Susan L Tucker; Joe B Putnam; Jaffer A Ajani; Zhongxing Liao; Stephen G Swisher; Jack A Roth; W Roy Smythe; Garrett L Walsh; Radhe Mohan; Hui H Liu; Deidre Mooring; Ritsuko Komaki
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
International journal of radiation oncology, biology, physics 2003;57(5):1317-22.
2003: Anesa Ahamad; Craig W Stevens; W Roy Smythe; Zhongxing Liao; Ara A Vaporciyan; David Rice; Garrett Walsh; Thomas Guerrero; Joe Chang; Brent Bell; Ritsuko Komaki; Kenneth Forster
Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest.
Cancer journal (Sudbury, Mass.) 2003;9(6):476-84.
2003: David Rice; Hyung Woo Kim; Anita L Sabichi; Scott Lippman; J Jack Lee; Brendell Williams; Ara A Vaporciyan; W Roy Smythe; Stephen G Swisher; Garrett Walsh; Joe B Putnam; Waun Ki Hong; Jack Roth
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
The Annals of thoracic surgery 2003;76(4):1001-7; discussion 1007-8.
2003: Stephen G Swisher; Jaffer A Ajani; Ritsuko Komaki; Jonathan C Nesbitt; Arlene M Correa; James D Cox; Sandeep Lahoti; Faye Martin; Joe B Putnam; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
International journal of radiation oncology, biology, physics 2003;57(1):120-7.
2003: Freddy Angulo-Pernett; W Roy Smythe
Primary lymphoepithelioma of the esophagus.
The Annals of thoracic surgery 2003;76(2):603-5.
2003: W Roy Smythe
The first American textbook of surgery.
Annals of surgery 2003;237(4):580-90.
2003: Anesa Ahamad; Craig W Stevens; W Roy Smythe; Ara A Vaporciyan; Ritsuko Komaki; Jason F Kelly; Zhongxing Liao; George Starkschall; Kenneth Forster
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
International journal of radiation oncology, biology, physics 2003;55(3):768-75.
2003: Kenneth Forster; W Roy Smythe; George Starkschall; Zhongxing Liao; Tsuyoshi Takanaka; Jason F Kelly; Ara A Vaporciyan; Anesa Ahamad; Lei Dong; Mohammad Salehpour; Ritsuko Komaki; Craig W Stevens
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
International journal of radiation oncology, biology, physics 2003;55(3):606-16.
2003: W Roy Smythe
The American surgical spirit.
Journal of the American College of Surgeons 2003;196(2):250-2.
2003: Jonathan C Daniel; W Roy Smythe
Gene therapy of lung cancer.
Seminars in surgical oncology 2003;21(3):196-204.
2003: W Roy Smythe
Treatment of stage I non-small cell lung carcinoma.
Chest 2003;123(1 Suppl):181S-187S.
2002: Xiaobo X Cao; Imran Mohuiddin; Sunil Chada; Abner M Mhashilkar; Mustafa K Ozvaran; David J McConkey; Steven D Miller; Jonathan C Daniel; W Roy Smythe
Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL.
Molecular medicine (Cambridge, Mass.) 2002;8(12):869-76.
2002: Wayne L Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Treatment outcomes of resected esophageal cancer.
Annals of surgery 2002;236(3):376-84; discussion 384-5.
2002: W Roy Smythe
Current therapy for malignant mesothelioma.
Current oncology reports 2002;4(4):305-13.
2002: W Roy Smythe; Imran Mohuiddin; Mustafa Ozveran; Xiaobo X Cao
Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.
The Journal of thoracic and cardiovascular surgery 2002;123(6):1191-8.
2002: Imran Mohiuddin; Xiaobo Cao; Mustafa K Ozvaran; Louis Zumstein; Sunil Chada; W Roy Smythe
Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation.
Annals of surgical oncology 2002;9(3):310-6.
2002: W Roy Smythe
Gene therapy for thoracic disease: practice, promise, and pragmatism.
The Annals of thoracic surgery 2002;73(3):704-6.
2002: Ara A Vaporciyan; Kelly W Merriman; Ferrah Ece; Jack A Roth; W Roy Smythe; Stephen G Swisher; Garrett L Walsh; Jonathan C Nesbitt; Joe B Putnam
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.
The Annals of thoracic surgery 2002;73(2):420-5; discussion 425-6.
2002: Stephen G Swisher; Paula Wynn; Joe B Putnam; Melinda B Mosheim; Arlene M Correa; Ritsuko Komaki; Jaffer A Ajani; W Roy Smythe; Ara A Vaporciyan; Jack A Roth; Garrett L Walsh
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.
The Journal of thoracic and cardiovascular surgery 2002;123(1):175-83.
2001: Xiaobo X Cao; Imran Mohuiddin; Ferrah Ece; David J McConkey; W Roy Smythe
Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
American journal of respiratory cell and molecular biology 2001;25(5):562-8.
2001: Xiang Y Han; Audrey S Pham; K U Nguyen; W Roy Smythe; Nelson G Ordonez; Kalen L Jacobson; Jeffrey J Tarrand
Pulmonary granuloma caused by Pseudomonas andersonii sp nov.
American journal of clinical pathology 2001;116(3):347-53.
2001: Imran Mohiuddin; Xiaobo Cao; Bingliang Fang; M Nishizaki; W Roy Smythe
Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
Cancer gene therapy 2001;8(8):547-54.
2001: M P Siegenthaler; Katherine M W Pisters; Kelly W Merriman; Jack A Roth; Stephen G Swisher; Garrett L Walsh; Ara A Vaporciyan; W Roy Smythe; Joe B Putnam
Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
The Annals of thoracic surgery 2001;71(4):1105-11; discussion 1111-2.
2001: W Roy Smythe; A L Estrera; Stephen G Swisher; Kelly W Merriman; Garrett L Walsh; Joe B Putnam; Ara A Vaporciyan; Jack A Roth
Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma.
The Annals of thoracic surgery 2001;71(3):962-6.
2001: Abujiang Pataer; W Roy Smythe; R Yu; Bingliang Fang; Timothy J McDonnell; Jack A Roth; Stephen G Swisher
Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines.
The Journal of thoracic and cardiovascular surgery 2001;121(1):61-7.
2001: Garrett L Walsh; B M Davis; Stephen G Swisher; Ara A Vaporciyan; W Roy Smythe; K Willis-Merriman; Jack A Roth; Joe B Putnam
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections.
The Journal of thoracic and cardiovascular surgery 2001;121(1):48-60.
2000: W Roy Smythe
Benjamin Rush's death.
Journal of the American College of Surgeons 2000;190(4):471-82.
2000: Joe B Putnam; Garrett L Walsh; Stephen G Swisher; Jack A Roth; D M Suell; Ara A Vaporciyan; W Roy Smythe; Kelly W Merriman; L L DeFord
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
The Annals of thoracic surgery 2000;69(2):369-75.
2000: W Roy Smythe
Prodrug/drug sensitivity gene therapy: current status.
Current oncology reports 2000;2(1):17-22.
1999: W Roy Smythe; J P Williams; M J Wheelock; K R Johnson; Larry R Kaiser; S M Albelda
Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;24(3):157-68.
1998: Darren B Taichman; Gregory Tino; Judith Aronchick; C Reynolds; W Roy Smythe; JR Roberts; D Haller
Diffuse airway narrowing from carcinoma metastatic to the bronchial submucosa: identification by chest CT.
Chest 1998;114(4):1217-20.
1998: W Roy Smythe; Joseph E Bavaria; Larry R Kaiser
Mediastinoscopic subtotal removal of mediastinal cysts.
Chest 1998;114(2):614-7.
1998: M Liu; P S Kim; C K Chen; W Roy Smythe
Delayed Horner's syndrome as a complication of continuous thoracic epidural analgesia.
Journal of cardiothoracic and vascular anesthesia 1998;12(2):195-6.
1998: JR Roberts; P S Abbott; W Roy Smythe; Joseph E Bavaria
Resection of a pulmonary malignancy invading the intrapericardial inferior vena cava.
The Annals of thoracic surgery 1998;65(1):263-5.
1997: W Roy Smythe; D Wasfi; Joseph E Bavaria; Steven M Albelda; Larry R Kaiser
Loss of alpha-v integrin expression and recurrence in node-negative lung carcinoma.
The Annals of thoracic surgery 1997;64(4):949-53.
1997: JR Roberts; W Roy Smythe; R W Weber; M Lanutti; Bruce R Rosengard; Larry R Kaiser
Thoracoscopic management of descending necrotizing mediastinitis.
Chest 1997;112(3):850-4.
1996: AA Elshami; J C Kucharczuk; H B Zhang; W Roy Smythe; H C Hwang; Leslie A Litzky; Larry R Kaiser; Steven M Albelda
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene.
Human gene therapy 1996;7(2):141-8.
1995: W Roy Smythe; E LeBel; Joseph E Bavaria; Larry R Kaiser; Steven M Albelda
Integrin expression in non-small cell carcinoma of the lung.
Cancer metastasis reviews 1995;14(3):229-39.
1995: J C Kucharczuk; AA Elshami; H B Zhang; W Roy Smythe; H C Hwang; J S Tomlinson; Kunjlata M Amin; Leslie A Litzky; Steven M Albelda; Larry R Kaiser
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.
The Annals of thoracic surgery 1995;60(3):593-7; discussion 597-8.
1995: AA Elshami; J C Kucharczuk; Daniel H Sterman; W Roy Smythe; H C Hwang; Kunjlata M Amin; Leslie A Litzky; Steven M Albelda; Larry R Kaiser
The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.
Annals of surgery 1995;222(3):298-307; 307-10.
1995: W Roy Smythe; H C Hwang; AA Elshami; Kunjlata M Amin; Stephen L Eck; Beverly L Davidson; James M Wilson; Larry R Kaiser; Steven M Albelda
Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.
Annals of surgery 1995;222(1):78-86.
1995: H C Hwang; W Roy Smythe; AA Elshami; J C Kucharczuk; Kunjlata M Amin; J P Williams; Leslie A Litzky; Larry R Kaiser; Steven M Albelda
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer.
American journal of respiratory cell and molecular biology 1995;13(1):7-16.
1995: W Roy Smythe; H C Hwang; AA Elshami; Kunjlata M Amin; Steven M Albelda; Larry R Kaiser
Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy.
The Journal of thoracic and cardiovascular surgery 1995;109(4):626-30; discussion 630-1.
1995: Kunjlata M Amin; Leslie A Litzky; W Roy Smythe; A M Mooney; J M Morris; D J Mews; Harvey I Pass; Csaba Kari; Ulrich Rodeck; Frank J Rauscher
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
The American journal of pathology 1995;146(2):344-56.
1995: W Roy Smythe; Joseph E Bavaria; R A Hall; Gary Kline; Larry R Kaiser
Thoracoscopic removal of mediastinal parathyroid adenoma.
The Annals of thoracic surgery 1995;59(1):236-8.
1994: W Roy Smythe; Larry R Kaiser; H C Hwang; Kunjlata M Amin; J M Pilewski; S J Eck; James M Wilson; Steven M Albelda
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.
The Annals of thoracic surgery 1994;57(6):1395-401.
1994: W Roy Smythe; H C Hwang; Kunjlata M Amin; Stephen L Eck; Beverly L Davidson; James M Wilson; Larry R Kaiser; Steven M Albelda
Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Cancer research 1994;54(8):2055-9.
1993: W Roy Smythe; Joseph E Bavaria
Tetracycline pleurodesis--associated acute renal failure.
Chest 1993;104(4):1274-6.
1990: D A Mandelbrot; W Roy Smythe; Sandra A Norman; S C Martin; Arnold Robert; G H Talbot; PD Stolley
A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virus.
Surgery, gynecology & obstetrics 1990;171(2):99-106.
1989: Donald C Dafoe; W Roy Smythe; R Berezniak; Lorraine Tafra; L M Shaw; John E Tomaszewski; Clyde F Barker
An innovative site for fetal pancreas transplantation in rats--the subserosa of a U loop of small intestine.
Transplantation 1989;48(5):863-5.
1988: Kenneth L Brayman; Donald C Dafoe; W Roy Smythe; Clyde F Barker; L J Perloff; A Naji; I J Fox; Robert A Grossman; Diane K Jorkasky; S E Starr
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial.
Archives of surgery (Chicago, Ill. : 1960) 1988;123(12):1502-8.